Cost of Goods Analysis Facilitates an Integrated Approach to Identifying Alternative Synthesis Methodologies for Lower Cost Manufacturing of the COVID-19 Antiviral Molnupiravir

Orally delivered drugs offer significant benefits in the fight against viral infections, and cost-effective production is critical to their impact on pandemic response in low- and middle-income countries. One example, molnupiravir, a COVID-19 therapy developed by Emory, Ridgeback, and Merck & Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Christopher, Paria, Sayan, Deshpande, Anita, Ahmad, Saeed, Harmon, Andrew, Dillon, John, Laird, Trevor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901586/
https://www.ncbi.nlm.nih.gov/pubmed/35299948
http://dx.doi.org/10.12688/gatesopenres.13509.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901586/
https://www.ncbi.nlm.nih.gov/pubmed/35299948
http://dx.doi.org/10.12688/gatesopenres.13509.1

Ejemplares similares